Cargando…
The natural course of bacillus Calmette-Guérin induced bladder lesions: A long-term follow-up study and systematic review
OBJECTIVE: Bacillus Calmette-Guérin (BCG) instillation is the standard adjuvant treatment for intermediate- and high-risk non-muscle-invasive bladder cancer after transurethral resection. Nevertheless, its toxicity often causes bladder complications. On follow-up cystoscopy, post-BCG bladder lesions...
Autores principales: | Ma, Chong, Zeng, Shuxiong, Dai, Lihe, Han, Huan, Song, Ruixiang, Xu, Jinshan, Ai, Xing, Xu, Chuanliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Second Military Medical University
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394293/ https://www.ncbi.nlm.nih.gov/pubmed/37538149 http://dx.doi.org/10.1016/j.ajur.2022.12.006 |
Ejemplares similares
-
Low-Dose Versus Standard Dose of Bacillus Calmette-Guerin in the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis
por: Zeng, Shuxiong, et al.
Publicado: (2015) -
Clinical Course of Bacillus Calmette-Guerin Lymphadenitis
por: Ko, Dayoung, et al.
Publicado: (2022) -
AB139. Low-dose versus standard dose of bacillus Calmette-Guerin in the treatment of non-muscle invasive bladder cancer
por: Xu, Chuanliang
Publicado: (2016) -
Bacillus Calmette-Guérin in the management of superficial bladder cancer
por: Kapoor, Rakesh, et al.
Publicado: (2008) -
Predictive biomarkers of response to bacillus Calmette‐Guérin immunotherapy and bacillus Calmette‐Guérin failure for non‐muscle invasive bladder cancer
por: Wang, Ziting, et al.
Publicado: (2022)